1st Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$235,284
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Labor HHS Appropriations

LobbyistCovered position, as disclosed
RAY QUINTERO VP Government Relations
JOHN MICHAEL C. VILLARAMA New Government Relations Associate
LAURA WOOSTER Associate VP Government Relations

Contacted: Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); White House Office; Agency for Healthcare Research & Quality (AHRQ); Office of Management & Budget (OMB)

Defense DEF

Recognition of Osteopathic Certification

LobbyistCovered position, as disclosed
RAY QUINTERO VP Government Relations
JOHN MICHAEL C. VILLARAMA New Government Relations Associate
LAURA WOOSTER Associate VP Government Relations

Contacted: Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); White House Office; Office of Management & Budget (OMB); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP)

Taxation/Internal Revenue Code TAX

Flexible Spending Accounts; Health Savings Accounts

LobbyistCovered position, as disclosed
RAY QUINTERO VP Government Relations
JOHN MICHAEL C. VILLARAMA New Government Relations Associate
LAURA WOOSTER Associate VP Government Relations

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Office of Management & Budget (OMB); SENATE; Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC)

Torts TOR

Professional Liability Insurance; Medical Liability Reform

LobbyistCovered position, as disclosed
RAY QUINTERO VP Government Relations
JOHN MICHAEL C. VILLARAMA New Government Relations Associate
LAURA WOOSTER Associate VP Government Relations

Contacted: White House Office; Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); SENATE

Health Issues HCR

Medicare Physician Payments Reform, Patient access to care; Graduate Medical Education; Physician Workforce Issues; Health reform implementation (PL 111-148); Telehealth (Health Information Technology)

LobbyistCovered position, as disclosed
RAY QUINTERO VP Government Relations
JOHN MICHAEL C. VILLARAMA New Government Relations Associate
LAURA WOOSTER Associate VP Government Relations

Contacted: Office of Management & Budget (OMB); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); SENATE; Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); White House Office

Medicare/Medicaid MMM

Graduate Medical Education; Health Care Quality, Patient Access to Health Care; Physician Workforce; Medicare Physician Payment Issues; Independent Payment Advisory Board. H.R. 574, The Medicare Physician Payment Innovation Act of 2013.

LobbyistCovered position, as disclosed
RAY QUINTERO Vice President Government Relations
JOHN MICHAEL C. VILLARAMA New Government Relations Associate
LAURA WOOSTER Associate VP Government Relations

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); White House Office; Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); SENATE; Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS)

Bills named: H.R. 574 (114th)

Insurance INS

Health Insurance; Professional Liability Insurance; State Insurance Marketplace

LobbyistCovered position, as disclosed
RAY QUINTERO VP Government Relations
JOHN MICHAEL C. VILLARAMA New Government Relations Associate
LAURA WOOSTER Associate VP Government Relations

Contacted: Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); SENATE; Office of Management & Budget (OMB); Executive Office of the President (EOP); Food & Drug Administration (FDA); Government Accountability Office (GAO); White House Office; Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES

Education EDU

Student Loan Financing and Re-Financing

LobbyistCovered position, as disclosed
RAY QUINTERO VP Government Relations
JOHN MICHAEL C. VILLARAMA New Government Relations Associate
LAURA WOOSTER Associate VP Government Relations

Contacted: Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); Office of Management & Budget (OMB); Government Accountability Office (GAO); White House Office; Health Resources & Services Administration (HRSA)

Medical/Disease Research/Clinical Labs MED

NIH; FDA; Agency for Health Care Quality & Research Funding

LobbyistCovered position, as disclosed
RAY QUINTERO VP Government Relations
JOHN MICHAEL C. VILLARAMA New Government Relations Associate
LAURA WOOSTER Associate VP Government Relations

Contacted: Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.